1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Nucleic Acid-based Drugs Market Size 2024-2029 2.1.2 Nucleic Acid-based Drugs Market Size CAGR by Region 2.2 Nucleic Acid-based Drugs Segment by Type 2.2.1 ASO 2.2.2 mRNA 2.2.3 siRNA 2.2.4 miRNA 2.2.5 saRNA 2.2.6 Aptamer 2.3 Nucleic Acid-based Drugs Market Size by Type 2.3.1 Global Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) 2.3.2 Global Nucleic Acid-based Drugs Market Size Growth Rate by Type (2024-2029) 2.4 Nucleic Acid-based Drugs Segment by Application 2.4.1 Genetic Disease 2.4.2 Cancer 2.4.3 Cardiovascular Diseases 2.4.4 Other 2.5 Nucleic Acid-based Drugs Market Size by Application 2.5.1 Global Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) 2.5.2 Global Nucleic Acid-based Drugs Market Size Growth Rate by Application (2024-2029) 3 Nucleic Acid-based Drugs Key Players 3.1 Date of Key Players Enter into Nucleic Acid-based Drugs 3.2 Key Players Nucleic Acid-based Drugs Product Offered 3.3 Key Players Nucleic Acid-based Drugs Funding/Investment Analysis 3.4 Funding/Investment 3.4.1 Funding/Investment by Regions 3.4.2 Funding/Investment by End-Industry 3.5 Key Players Nucleic Acid-based Drugs Valuation & Market Capitalization 3.6 Key Players Mergers & Acquisitions, Expansion Plans 3.7 Market Ranking 3.8 New Product/Technology Launches 3.9 Partnerships, Agreements, and Collaborations 3.10 Mergers and Acquisitions 4 Nucleic Acid-based Drugs by Regions 4.1 Nucleic Acid-based Drugs Market Size by Regions (2024-2029) 4.2 United States Nucleic Acid-based Drugs Market Size Growth (2024-2029) 4.3 China Nucleic Acid-based Drugs Market Size Growth (2024-2029) 4.4 Europe Nucleic Acid-based Drugs Market Size Growth (2024-2029) 4.5 Rest of World Nucleic Acid-based Drugs Market Size Growth (2024-2029) 5 United States 5.1 United States Nucleic Acid-based Drugs Market Size by Type (2024-2029) 5.2 United States Nucleic Acid-based Drugs Market Size by Application (2024-2029) 6 Europe 6.1 Europe Nucleic Acid-based Drugs Market Size by Type (2024-2029) 6.2 Europe Nucleic Acid-based Drugs Market Size by Application (2024-2029) 7 China 7.1 China Nucleic Acid-based Drugs Market Size by Type (2024-2029) 7.2 China Nucleic Acid-based Drugs Market Size by Application (2024-2029) 8 Rest of World 8.1 Rest of World Nucleic Acid-based Drugs Market Size by Type (2024-2029) 8.2 Rest of World Nucleic Acid-based Drugs Market Size by Application (2024-2029) 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Key Investors in Nucleic Acid-based Drugs 10.1 Company A 10.1.1 Company A Company Details 10.1.2 Company Description 10.1.3 Companies Invested by Company A 10.1.4 Company A Key Development and Market Layout 10.2 Company B 10.2.1 Company B Company Details 10.2.2 Company Description 10.2.3 Companies Invested by Company B 10.2.4 Company B Key Development and Market Layout 10.3 Company C 10.3.1 Company C Company Details 10.3.2 Company Description 10.3.3 Companies Invested by Company C 10.3.4 Company C Key Development and Market Layout 10.4 Company D 10.5 …… 11 Key Players Analysis 11.1 Ionis Pharmaceuticals 11.1.1 Ionis Pharmaceuticals Company Details 11.1.2 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Offered 11.1.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029) 11.1.4 Ionis Pharmaceuticals Main Business Overview 11.1.5 Ionis Pharmaceuticals News 11.2 Sarepta Therapeutics 11.2.1 Sarepta Therapeutics Company Details 11.2.2 Sarepta Therapeutics Nucleic Acid-based Drugs Product Offered 11.2.3 Sarepta Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) 11.2.4 Sarepta Therapeutics Main Business Overview 11.2.5 Sarepta Therapeutics News 11.3 Nippon Shinyaku 11.3.1 Nippon Shinyaku Company Details 11.3.2 Nippon Shinyaku Nucleic Acid-based Drugs Product Offered 11.3.3 Nippon Shinyaku Nucleic Acid-based Drugs Market Size (2023 VS 2029) 11.3.4 Nippon Shinyaku Main Business Overview 11.3.5 Nippon Shinyaku News 11.4 BioNTech 11.4.1 BioNTech Company Details 11.4.2 BioNTech Nucleic Acid-based Drugs Product Offered 11.4.3 BioNTech Nucleic Acid-based Drugs Market Size (2023 VS 2029) 11.4.4 BioNTech Main Business Overview 11.4.5 BioNTech News 11.5 Moderna Therapeutics 11.5.1 Moderna Therapeutics Company Details 11.5.2 Moderna Therapeutics Nucleic Acid-based Drugs Product Offered 11.5.3 Moderna Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) 11.5.4 Moderna Therapeutics Main Business Overview 11.5.5 Moderna Therapeutics News 11.6 CureVac 11.6.1 CureVac Company Details 11.6.2 CureVac Nucleic Acid-based Drugs Product Offered 11.6.3 CureVac Nucleic Acid-based Drugs Market Size (2023 VS 2029) 11.6.4 CureVac Main Business Overview 11.6.5 CureVac News 11.7 Alnylam Pharmaceuticals 11.7.1 Alnylam Pharmaceuticals Company Details 11.7.2 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product Offered 11.7.3 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029) 11.7.4 Alnylam Pharmaceuticals Main Business Overview 11.7.5 Alnylam Pharmaceuticals News 11.8 Regulus Therapeutics 11.8.1 Regulus Therapeutics Company Details 11.8.2 Regulus Therapeutics Nucleic Acid-based Drugs Product Offered 11.8.3 Regulus Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) 11.8.4 Regulus Therapeutics Main Business Overview 11.8.5 Regulus Therapeutics News 11.9 Miragen Therapeutics 11.9.1 Miragen Therapeutics Company Details 11.9.2 Miragen Therapeutics Nucleic Acid-based Drugs Product Offered 11.9.3 Miragen Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) 11.9.4 Miragen Therapeutics Main Business Overview 11.9.5 Miragen Therapeutics News 11.10 Mina Therapeutics 11.10.1 Mina Therapeutics Company Details 11.10.2 Mina Therapeutics Nucleic Acid-based Drugs Product Offered 11.10.3 Mina Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) 11.10.4 Mina Therapeutics Main Business Overview 11.10.5 Mina Therapeutics News 11.11 NeXstar Pharmaceuticals 12 Research Findings and Conclusion

List of Tables Table 1. Nucleic Acid-based Drugs Market Size CAGR by Region (2024-2029) ($ Millions) Table 2. Major Players of ASO Table 3. Major Players of mRNA Table 4. Major Players of siRNA Table 5. Major Players of miRNA Table 6. Major Players of saRNA Table 7. Major Players of Aptamer Table 8. Global Nucleic Acid-based Drugs Market Size by Type (2024-2029) ($ Millions) Table 9. Global Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Table 10. Global Nucleic Acid-based Drugs Market Size by Application (2024-2029) ($ Millions) Table 11. Global Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Table 12. Date of Global Key Players Enter into Nucleic Acid-based Drugs Market Table 13. Global Key Players Nucleic Acid-based Drugs Product Offered Table 14. Key Players Nucleic Acid-based Drugs Funding/Investment ($ Millions) Table 15. Funding/Investment by Regions Table 16. Funding/Investment by End Industry Table 17. Key Players Nucleic Acid-based Drugs Valuation & Market Capitalization ($ Millions) Table 18. Key Players Mergers & Acquisitions, Expansion Plans Table 19. Nucleic Acid-based Drugs New Product/Technology Launches Table 20. Nucleic Acid-based Drugs Industry Partnerships, Agreements, and Collaborations Table 21. Nucleic Acid-based Drugs Industry Mergers and Acquisitions Table 22. Global Nucleic Acid-based Drugs Market Size by Regions 2024-2029 ($ Millions) Table 23. Global Nucleic Acid-based Drugs Market Size Market Share by Regions 2024-2029 Table 24. United States Nucleic Acid-based Drugs Market Size by Type (2024-2029) ($ Millions) Table 25. United States Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Table 26. United States Nucleic Acid-based Drugs Market Size by Application (2024-2029) ($ Millions) Table 27. United States Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Table 28. Europe Nucleic Acid-based Drugs Market Size by Type (2024-2029) ($ Millions) Table 29. Europe Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Table 30. Europe Nucleic Acid-based Drugs Market Size by Application (2024-2029) ($ Millions) Table 31. Europe Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Table 32. China Nucleic Acid-based Drugs Market Size by Type (2024-2029) ($ Millions) Table 33. China Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Table 34. China Nucleic Acid-based Drugs Market Size by Application (2024-2029) ($ Millions) Table 35. China Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Table 36. Rest of World Nucleic Acid-based Drugs Market Size by Type (2024-2029) ($ Millions) Table 37. Rest of World Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Table 38. Rest of World Nucleic Acid-based Drugs Market Size by Application (2024-2029) ($ Millions) Table 39. Rest of World Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Table 40. Key Market Drivers & Growth Opportunities of Nucleic Acid-based Drugs Table 41. Key Market Challenges & Risks of Nucleic Acid-based Drugs Table 42. Key Industry Trends of Nucleic Acid-based Drugs Table 43. Company A Company Details Table 44. Companies Invested by Company A Table 45. Company A Key Development and Market Layout Table 46. Company B Company Details Table 47. Companies Invested by Company B Table 48. Company B Key Development and Market Layout Table 49. Company C Company Details Table 50. Companies Invested by Company C Table 51. Company C Key Development and Market Layout Table 52. Company C Company Details Table 53. Companies Invested by Company C Table 54. Company C Key Development and Market Layout Table 55. Ionis Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors Table 56. Ionis Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 57. Sarepta Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 58. Sarepta Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 59. Nippon Shinyaku Basic Information, Head Office, Major Market Areas and Its Competitors Table 60. Nippon Shinyaku Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 61. BioNTech Basic Information, Head Office, Major Market Areas and Its Competitors Table 62. BioNTech Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 63. Moderna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 64. Moderna Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 65. CureVac Basic Information, Head Office, Major Market Areas and Its Competitors Table 66. CureVac Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 67. Alnylam Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors Table 68. Alnylam Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 69. Regulus Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 70. Regulus Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 71. Miragen Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 72. Miragen Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 73. Mina Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 74. Mina Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 75. NeXstar Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors Table 76. NeXstar Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029) List of Figures Figure 1. Picture of Nucleic Acid-based Drugs Figure 2. Nucleic Acid-based Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Nucleic Acid-based Drugs Market Size Growth Rate 2024-2029 ($ Millions) Figure 7. Nucleic Acid-based Drugs Market Size by Region (2023 & 2029) ($ millions) Figure 8. Global Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Figure 9. Global ASO Market Size Growth Rate Figure 10. Global mRNA Market Size Growth Rate Figure 11. Global siRNA Market Size Growth Rate Figure 12. Global miRNA Market Size Growth Rate Figure 13. Global saRNA Market Size Growth Rate Figure 14. Global Aptamer Market Size Growth Rate Figure 15. Nucleic Acid-based Drugs in Genetic Disease Figure 16. Global Nucleic Acid-based Drugs Market: Genetic Disease (2024-2029) ($ Millions) Figure 17. Nucleic Acid-based Drugs in Cancer Figure 18. Global Nucleic Acid-based Drugs Market: Cancer (2024-2029) ($ Millions) Figure 19. Nucleic Acid-based Drugs in Cardiovascular Diseases Figure 20. Global Nucleic Acid-based Drugs Market: Cardiovascular Diseases (2024-2029) ($ Millions) Figure 21. Nucleic Acid-based Drugs in Other Figure 22. Global Nucleic Acid-based Drugs Market: Other (2024-2029) ($ Millions) Figure 23. Global Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Figure 24. Global Nucleic Acid-based Drugs Market Size in Genetic Disease Growth Rate Figure 25. Global Nucleic Acid-based Drugs Market Size in Cancer Growth Rate Figure 26. Global Nucleic Acid-based Drugs Market Size in Cardiovascular Diseases Growth Rate Figure 27. Global Nucleic Acid-based Drugs Market Size in Other Growth Rate Figure 28. Funding/Investment Figure 29. Global Nucleic Acid-based Drugs Market Size Market Share by Regions 2024-2029 Figure 30. United States Nucleic Acid-based Drugs Market Size 2024-2029 ($ Millions) Figure 31. China Nucleic Acid-based Drugs Market Size 2024-2029 ($ Millions) Figure 32. Europe Nucleic Acid-based Drugs Market Size 2024-2029 ($ Millions) Figure 33. Rest of World Nucleic Acid-based Drugs Market Size 2024-2029 ($ Millions) Figure 34. United States Nucleic Acid-based Drugs Consumption Market Share by Type in 2029 Figure 35. United States Nucleic Acid-based Drugs Market Size Market Share by Application in 2029 Figure 36. China Nucleic Acid-based Drugs Consumption Market Share by Type in 2029 Figure 37. China Nucleic Acid-based Drugs Market Size Market Share by Application in 2029 Figure 38. Europe Nucleic Acid-based Drugs Consumption Market Share by Type in 2029 Figure 39. Europe Nucleic Acid-based Drugs Market Size Market Share by Application in 2029 Figure 40. Rest of World Nucleic Acid-based Drugs Consumption Market Share by Type in 2029 Figure 41. Rest of World Nucleic Acid-based Drugs Market Size Market Share by Application in 2029